Bacteria on display—can we, and should we? Artistically exploring the ethics of public engagement with science in microbiology

Just out in the latest issue of FEMS Microbiology Letters is a small commentary by myself and Artist Anna Dumitriu, describing our experience of collaborating on Microbiology/Art public engagement pieces. We focus on the ethical issues involved in displaying bacteria publicly, how to address the risks involved, and projects that can open up wider debates around the ethics of new technologies, namely the Trust me I’m an Artist collaboration.

Can we display bacteria from poop? If we do, how can we minimise the risk? And who gets a say in whether we should or not?

The shiny full published version can be found: at

Accepted manuscript for those who don’t have access to paywall can be downloaded here: FEMSLE_accepted_manuscript


Figure 1 The MRSA Quilt

Figure 1: The MRSA Quilt The quilting squares were added to Methicillin-resistant Staphylococcus aureus cultures on chromogenic agar. Standard antibiotic susceptibility testing equipment was used to create the patterns, together with other known antimicrobial pigments and dyes. The whole work was autoclaved prior to display. It serves as a tactile, aesthetic ‘conversation piece’, as microbiological techniques are described to explain how the effects are achieved. More information on this piece and more can be found at

Figure 2 Sequence Dress

Figure 2: Sequence Dress The dress was created using material impregnated and patterned using Staphylococcus aureus culture on chromogenic agar. DNA from Staphylococcus aureus cultured from Dumitriu’s body was sequenced using an Illumina Miseq, and the light output from the flow cells captured and mapped digitally onto a dress. The DNA sequence was projected behind. The piece has been exhibited internationally, and serves to highlight new technologies in the field of Microbiology.

This is a pre-copyedited, author-produced version of an article accepted for publication in FEMS  Micro Letters following peer review. The version of record [Nicola J Fawcett, Anna Dumitriu; Bacteria on display—can we, and should we? Artistically exploring the ethics of public engagement with science in microbiology] is available online at: .

Ibogaine, arrythmias, risks, and a memorable day on the medical take

I saw a report on the BBC today about heroin addicts in the US seeking treatment abroad for their addiction with a novel (and illegal) psychoactive drug, Ibogaine.  It’s a fascinating story – the patient goes in with a long-term and devastating addiction,  experiences a day or two of vivid, often insightful, hallucinations, and in many cases, leaves no-longer dependent.  Unfortunately further roll-out of this treatment has been hampered by both legal/financial issues, and a worry about unexplained fatalities, and there’s an increasing body of evidence that this drug can cause cardiac arrythmias, leading to arrest.

I remember well the day when we admitted someone with Ibogaine-induced-cardiac arrythmias.

I quote from the case report:

“A 39-year-old man was brought to hospital after suffering 3 seizures”.  “Approximately 3 h later, the patient had an episode of self-limiting pulseless polymorphic VT.  He was moved to the resuscitation area where he went on to have 7 additional episodes of polymorphic VT that were successfully terminated with electrical cardioversion.”

Depending on your existing level of medical experience, that sentence is either mildly interesting, or something that makes you go  “OOEEERRRGH”.

It was pretty “OOEEERRGH” at the time.    I remember vividly standing in our admissions unit (with no background other than the fact he’d been admitted with seizures), looking through his triage notes, and watching the cardiac monitor above him go  doo de dooo de dooo (as I imagine cardiac monitors do when they have nothing to report)  ‘WEEEEEEEEEEEEE!’  as the screen filled with cardiac badness and the patient suddenly looked a bit crap.


Image: Polymorphic VT, AKA Cardiac Badness in similar form to that encountered in this case. Source:  EKG World Encyclopedia , courtesy of Michael Rosengarten BEng, MD.McGill


Continue reading

Peppa Pig and Primary Care Services:Improved Version

This great Christmas BMJ article considers whether portrayal of general practice in Peppa Pig raises patient expectation and encourages inappropriate use of primary care services.

In the spirit of the article, I would like to suggest an improved Peppa Pig episode that could be used to convey more realistic expectations, encourage safe self-management and use primary care services more effectively .

Previously : Case study 2: George catches a cold (quoted in the article) 

Parents call Dr Brown Bear on a Saturday regarding an 18 month old piglet with a 2 minute history of coryzal symptoms after playing outside without his rain hat.

Dr Brown Bear telephone triages and makes an urgent home visit.

After examining the throat, he diagnoses an upper respiratory tract infection and advises bed rest and warm milk. Symptoms resolve within 12 hours.

New : George catches a cold (more realistic suggestion ) 

George Pig has a fever and is grumpy as hell. Mummy Pig knows the score from previous experience. She checks the NHS website just to be sure, and notes George has none of the concerning signs that would suggest she needs to seek further medical advice.


She goes to the local pharmacy and has a constructive conversation with the pharmacist, and is given some pink medicine for George Pig. She goes home and attempts to syringe some pink medicine into George Pig’s mouth until roughly equal quantities of medicine have gone into George, on the carpet and in Mummy Pig’s face.  George Pig is eventually only placated by bottle and daddy’s smartphone, and doesn’t want to sleep for more than 20 minutes at a time unless he is in Mummy Pig’s arms and being rocked.

Continue reading

Great articles on antibiotic use in animals

Scientific American: How Drug-Resistant Bacteria Travel from the Farm to Your Table

The Atlantic: Apocalypse Pig: The Last Antibiotic Begins to Fail

Bloomberg: Indian Poultry Farms Are Breeding Drug-Resistant Superbugs



The cautionary tale of the phage cocktails

A lovely little case report has just come out in AAC, about a patient with pretty terminal multidrug-resistant Acinetobacter baumanii infection being treated with a cocktail of bacteria-destroying phages.

I like to hear little radio reports from planet phage every now and then, as I do get asked  about them quite a lot when talking antibiotic apocalypses.


It’s well worth a read for those who want a quick insight, as it’s like a microcosm of the phage therapy world all in one patient – all the hopes, limitations, concerns, all in a very nicely written article.

Clever science? tick. Phages being inactivated by the patient’s own body? tick. Development of resistance by the bacteria? tick.  But also… possible clinical effect in someone with few options, and an excellent discussion about synergy between phages and antibiotics, Which I think boils down to ‘if you hit it with enough things simultaneously it goes down eventually’.

Continue reading